RWE in pharma: 5 minutes with…Kourtney Davis

Written by KOURTNEY DAVIS (JANSSEN PHARMACEUTICAL COMPANIES OF JOHNSON & JOHNSON)

RWE in pharma Kourtney Davis

In this ‘RWE in pharma’ interview series, we are putting various pharma experts in the spotlight and asking them to share their insight on how their industry has traditionally employed real-world evidence (RWE), how they envision this changing over the next few years and what their predictions of the impacts of the highly anticipated US FDA RWE Framework may be. Our expert for this instalment is Kourtney Davis, Therapy Area Epidemiology Matrix Head for the Janssen Pharmaceutical Companies of Johnson & Johnson (PA, USA). Please could you introduce yourself, your organization(s) and tell us more about your role?  As a Senior Director...

To view this content, please register now for access

It's completely free